How many insider declarations has Maizel Ari filed?

Maizel Ari has filed 3 public insider declarations with SEC (Form 4).

What is Maizel Ari's role?

Maizel Ari's reported role is not specified by the regulator across the filings.

Which companies does Maizel Ari report trades for?

Maizel Ari reports trades for Axsome Therapeutics, Inc..

What is Maizel Ari's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 1.2M€.

← Executives ★ Sign in to follow

MA

Maizel Ari

OFFICERM

·SEC (Form 4)

Axsome Therapeutics, Inc.

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€1m

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Browse the complete record of transactions filed by Maizel Ari. Director active across 1 company, notably Axsome Therapeutics, Inc.. Aggregated, 3 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €1.2m. History available since 21 January 2026. The latest transaction was disclosed on 22 April 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.

Companies and markets linked to Maizel Ari

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Axsome Therapeutics, Inc. (US)

Declarations3 total

◇

Maizel Ari

Chief Commercial OfficerExecutives22 Apr 2026Axsome Therapeutics, Inc.

$530,47518SEC ↗

7,500 shares@ US$70.730.0040% mcap27.9% of flowCommon StockSEC:0001193125-26-174415:0

▼

Maizel Ari

Chief Commercial OfficerExecutives22 Apr 2026Axsome Therapeutics, Inc.

$1M23SEC ↗

7,500 shares@ US$182.420.010% mcap72.1% of flowCommon StockSEC:0001193125-26-174415:1

◇

Maizel Ari

Chief Commercial OfficerExecutives21 Jan 2026Axsome Therapeutics, Inc.

$530,47513SEC ↗

7,500 shares@ US$70.7321.8% of flowCommon StockSEC:0001193125-26-021377:0

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

MA

Maizel Ari

OFFICERM

·SEC (Form 4)

Axsome Therapeutics, Inc.

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€1m

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Browse the complete record of transactions filed by Maizel Ari. Director active across 1 company, notably Axsome Therapeutics, Inc.. Aggregated, 3 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €1.2m. History available since 21 January 2026. The latest transaction was disclosed on 22 April 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.